Back

Integrated analysis of genomic and genome-wide association studies identified candidate genes for nutrigenetic studies in flavonoids and vascular health: path to precision nutrition for (poly)phenols

13 June 2026 (12:29 - 12:32)
Organised by: Logo
Seminar Presentation Part of: Module B: Mentoring & how-to sessions - Poster rapid fire session 4 Genetics, Epigenetics, ncRNA Premium Access Basic Science Course 2026 ESC Fund

About the speaker

Photo
Doctor Filip Postolov

(North Macedonia)

9 More presentations in this session

Presentation thumbnail
Investigating oxpl-mediated vascular inflammation in humanized Lp(a) transgenic mice: a preclinical study toward novel therapeutic strategies
Mr V. Antoniou (Athens, GR)
Video
Presentation thumbnail
Variant-specific drug responses in FH: an ex vivo pilot study
Mr R. Graca (Lisbon, PT)
Video
Presentation thumbnail
Transcriptomic analysis of mRNA in mouse model of chronic cigarette smoke-induced endothelial dysfunction treated with recombinant angiotensin-converting enzyme 2
Mr H. Hermawan (Surabaya, ID)
Video
Presentation thumbnail
Ruxolitinib attenuates cardio-renal inflammation via JAK-STAT and CaMKII signaling in hypertension
Ms M. Kiessling (Graz, AT)
Video
Presentation thumbnail
Role and mechanisms of the J1 gene in pulmonary arterial hypertension
Miss J. Ma (Guangzhou, CN)
Video

Access the full session

Session thumbnail
Module B: Mentoring & how-to sessions - Poster rapid fire session 4

The Event

Event poster

Basic Science Course 2026

13 June 2026 12:29 CET
You may be interested in
thumbnail
Seminar Presentation
Human genetic variations and pharmacogenomics
11 June 2026
thumbnail
Congress Presentation
Established and emerging blood pressure-lowering dietary interventions: from salt reduction to beetroot juice
29 August 2025
thumbnail
Congress Presentation
Integrative genomics identifies putative causal genes and therapeutic targets in thoracic aortic disease
29 August 2026
thumbnail
Seminar Presentation
Variant-specific drug responses in FH: an ex vivo pilot study
13 June 2026

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources